Clinical Trial Update: PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)

View source ↗

Summary

This is a completed update on the PROPOSE Quality study evaluating Preotact in postmenopausal osteoporosis, with a focus on quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Preotact (teriparatide)

Snippet

Sponsor: Nycomed | Conditions: Postmenopause, Osteoporosis | Status: COMPLETED